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The emerging Roles of Gamma–Delta 
T Cells in Tissue inflammation in 
experimental Autoimmune 
encephalomyelitis
Sakshi Malik , Muzamil Yaqub Want and Amit Awasthi*
Translational Health Science and Technology Institute, Faridabad, India
γδ (gamma–delta) T cells, a small population of unconventional T cells, have been found 
in central nervous system lesions of multiple sclerosis (MS) patients, but their function in 
disease activity is not clearly understood. Previous studies in experimental autoimmune 
encephalomyelitis (EAE) were inconsistent in identifying their specific roles in suppressing 
or promoting disease pathogenesis. Emerging advancements in the biology of γδ T cells 
especially in the context of their being the major initial producers of IL-17, suggested 
their crucial role in pathogenesis of EAE. In addition, γδ T cells express high levels of 
IL-23R and IL-1R, which further enhance their effector functions in the pathogenesis 
of EAE. Nonetheless, activated heterogeneous γδ T cells display functional dichotomy, 
which is crucial in determining the outcomes of tissue inflammation in EAE. In this review, 
we discussed recent advances in understanding the biology of γδ T cells in tissue inflam-
mation as well as their roles in suppressing or promoting the development of EAE.
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iNTRODUCTiON
γδ (gamma–delta) T cells comprise a small fraction (~1–5%) of the total blood lymphocytes of mice 
and humans and are more commonly localized in mucosal tissue and skin where they constitute a 
major population (up to 50%) of lymphocytes (1). The identification of an unusually rearranged γ 
chain of the T cell receptor (TCR) gene led to the discovery of γδ T cells (2, 3). After the identifica-
tion of γδ T cells as a new subset of T cells, it became clear that these cell types, unlike their αβ 
(alpha-beta) T cell counterparts, possess features of both innate and adaptive immune cells (4, 5). 
Moreover, γδ T cells have also been recognized as non-conventional innate-like cells as they share 
several features of innate immune cells, such as surface expression of Toll-like receptors (TLRs) (6). 
In addition, γδ T cells acquire preactivated phenotypes of effector and memory T cells during their 
early development (6).
The antigen recognition, activation, and effector functions of γδ T cells are different than those 
of their αβ T cell counterparts. Unlike αβ+ T cells, γδ T cells can be activated with or without their 
cognate TCR ligands and appear to induce an early burst of inflammatory cytokine that initiates 
effective and progressive αβ T cell responses in tissue inflammation during experimental autoim-
mune encephalomyelitis (EAE) (7–10). These unusual unique features of γδ T cells make them an 
early effector T cells during an immune response in inflamed tissue.
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αβ+ CD4+ T cells are crucial for inducing tissue inflammation 
in EAE. It has been convincingly elucidated that IL-17-producing 
Th17 cells are the major driver in inducing pathogenesis of EAE. 
Ablation of Th17 cells or absence of IL-17 significantly reduces 
the severity of inflammation in EAE (11). Similarly, the absence 
of Th17 cell-associated genes, such as Rorc, a master transcrip-
tion factor for Th17 cells development, and IL-23R also attenuate 
inflammation in EAE (12, 13). Interestingly, γδ T cells express 
higher level of IL-23R on their surface, which raised an interesting 
possibility that IL-23-responsive γδ T cells may contribute to the 
severity of tissue inflammation in EAE (8). Furthermore, GWAS 
studies suggested a genetic association of IL-23R with MS (14).
Although the bona fide antigens were identified for γδ T cells, 
still not much is known about their antigenic repertoire and 
restrictions (15). In addition to their antigens, γδ T cells can be 
activated by TLRs to induce various inflammatory cytokines, 
such as IFN-γ, IL-4, IL-17, IL-21, and IL-22 (6, 16).
Unlike αβ+ T cells, antigen recognition by the TCR of γδ T 
cells does not require antigen processing and presentation by 
MHC molecules (17, 18). Moreover, deficiencies of MHC class 
II and β2 microglobulin do not affect the development of γδ T 
cells and their repertoire remain intact, which suggest that the 
generation of γδ T cells is apparently independent of both class I 
and II molecules (19, 20). Interestingly, non-classical MHC class 
Ib molecules T10 and T22 are described as the natural ligands 
for murine γδ T cells (21, 22). Similarly, human class I-like mol-
ecules MICA and MICB were also suggested as natural antigens 
for human γδ T cells (21, 23–25). Interestingly, alterations in the 
expression of these ligands are induced by infection or tissue 
inflammation or stress, which can provide early danger-signal to 
initiate the activation of γδ T cells even in the absence of αβ+ T 
cells activation (15, 16).
The functions of γδ T cells in different pathophysiological 
conditions are driven by their tissue-specific distributions and 
tropism. At steady state, γδ T cells are predominantly localized 
in epithelial surfaces of liver, skin, and mucosal surfaces of diges-
tive, respiratory, and reproductive organs (15, 16). Moreover, 
the distribution of γδ T cells to the above mentioned epithelial 
and mucosal surfaces is often driven by their specific expression 
of invariant or closely related γδ TCRs; for example, Vγ6Vδ1 
TCR-expressing γδ T cells mostly accumulate in the lung, peri-
toneum, and reproductive organs, while Vγ5Vδ1-bearing γδ T 
cells predominantly reside in the epithelial surface of the skin 
(16). In addition to their tissue localization, cellular distribution, 
pathophysiological conditions, and inflammatory signals also 
determine the activation and phenotypic plasticity of γδ T cells.
Upon activation, γδ T cells can produce the effector cytokines 
of Th1, Th2, and Th17 cells, such as IFN-γ, IL-4, and IL-17, 
respectively, therefore contribute to specific effector function 
in Th1, Th2, and Th17 cell-associated tissue inflammation (26). 
Interestingly, IL-23 stimulation of γδ T cells rapidly induces IL-17 
production (6, 13, 27) to initiate tissue inflammation and enhance 
CD4+ αβ Th17 cells responses during EAE (7). It is apparent that 
γδ T cells play critical role in the induction and pathogenesis of 
EAE (15). Nonetheless, the regulatory role of γδ T cells is also 
suggested in EAE.
SUBSeTS OF γδ T CeLLS AND THeiR 
FUNCTiONS iN eAe
The functions of γδ T cells are not only critically required for 
elimination of intra- and extracellular pathogens and tissue 
surveillance in cancer but are also associated with multiple 
organ-specific autoimmunity, such as type 1 diabetes, arthritis, 
inflammatory bowel disease (IBD), and MS (16).
There are multiple subtypes of γδ T cells that are involved in 
the pathogenesis of EAE and can be identified based on the usage 
of their variable regions for both γ and δ genes (28, 29). Unlike 
the mucosal surfaces and the skin, which usually harbor higher 
frequency of γδ T cells, a smaller frequency of γδ T cells can be 
found within the central nervous system (CNS) in steady state of 
untreated naive mice (30, 31). Although the role of γδ T cells in 
the CNS at steady state is not precisely understood, it might be 
possible that their presence within the CNS could be required 
for carrying out immune surveillance function. Nonetheless, the 
frequency of γδ T cells profoundly increases within the CNS in 
EAE; and moreover, their distribution within the CNS can be 
classified based on their TCR usage during different phases of 
EAE (28). At the initial phase of EAE, CNS-infiltrating γδ T cells 
show a limited repertoire, including Vδ1, Vδ4, Vδ5, Vγ1–3, and 
Vγ6, while almost all the Vγ and Vδ transcripts can be found 
in the brain at the chronic or later phase of the disease (28). 
Although lymph nodes of EAE mice contained most of the Vγ 
transcripts during all phases of disease, a limited repertoire of γδ 
T cells was also observed within the CNS at the initial phase of the 
disease. Though Vγ6 (also known as DV7s6) expressing γδ T cells 
are predominantly located in mucosa, but they can also be found 
within the CNS at the initial phase of EAE. However, the precise 
antigen specificity of CNS-localized Vγ6 γδ T cells is not clearly 
understood in EAE. Since γδ T cells do not appear to recognize 
myelin basic protein (MBP) as antigen; therefore, Vγ6 T cells 
might be recruited to the CNS in EAE in response to the heat 
shock protein (HSP), which is expressed on stressed autologous 
cells (32). In addition, another possibility is that Vγ6 γδ T cells 
could recognize self-antigens that mimic bacterial peptide in the 
CNS during inflammation as this subset of γδ T cells is known 
to recognize microbial antigens (bacterial peptide) at mucosal 
surfaces (15, 33). Furthermore, γδ T cells are suggested to be func-
tionally dichotomous on the basis of their TCR usage in EAE; Vγ1 
subset preferentially regulates while Vγ4 subset further enhances 
tissue inflammation in EAE (34). Further analysis revealed that 
the Vγ1 subset is predominantly prevalent in spleen in all phases 
of EAE, and in fact, about 35–50% of total splenic γδ T cells are 
found to be Vγ1 in EAE (34). However, a small percentage of 
Vγ1 γδ T cells are also found in the CNS during EAE. Emerging 
literature suggested that Vγ1 γδ T cells act as regulatory cells and 
were shown to suppress tissue inflammation during the acute 
phase of EAE by enhancing the functions of Foxp3+ regulatory T 
(Treg) cells. Moreover, it is proposed that Vγ1 subset of γδ T cells 
highly express CCL4, which can bind to CCR5 on Treg cells and 
promote their suppressive functions in EAE (34). Consistent with 
their regulatory role in EAE, CNS-sorted Vγ1 γδ T cells from 
EAE mice do not express high amounts of IL-17A, IL-17F, IL-23R, 
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and GM-CSF, which further reinforce their regulatory function 
in EAE (34). Thus, it is suggested that Vγ1 subset might shift the 
balance away from Th17 cells while promoting the proliferation 
and suppressive functions of Treg cells during EAE.
Yet, another subset of γδ T cells, Vγ4 predominates in the 
CNS during EAE. These cells typically responds to self-antigens 
by producing pro inflammatory cytokine, such as IL-17, which in 
turn can directly act on stromal cells and induce migration of lym-
phocytes across blood brain barrier in EAE (8, 27). Interestingly, 
the IL-17-producing Vγ4 γδ T cells also expressed other Th17 
cell-associated molecules, such as Rorc, IL-22, IL-1R, and IL-1β 
(6, 34), which further suggested to contribute to inflammation and 
exacerbation of EAE (34). In addition to EAE, IL-17-producing 
Vγ4 γδ T cells are shown to promote collagen-induced arthritis 
(CIA), as antibody-mediated depletion of Vγ4 γδ T cells resulted 
in attenuated tissue inflammation in CIA (35). It is proposed that 
adjuvant rather antigen expands IL-17-producing Vγ4 γδ T cells 
in CIA.
The ability of γδ T cells to produce IL-17 innately in response 
to IL-23 in EAE could be attributed to Vγ4 subset of γδ T cells as 
they highly express IL-23R on their surface (6, 7, 27). Nonetheless, 
it is not clearly understood whether natural ligand or antigen of 
Vγ4 γδ T cells can induce strong IL-17 response in EAE. In addi-
tion to Vγ4 γδ T cells, Vγ6 γδ T cells, which primarily resides 
under the skin also express IL-23R on their surface, and therefore 
might be contributing to IL-17-mediated inflammation in the 
CNS of EAE mice (27).
Interestingly, in addition to IL-23R and Vγ4, the differential 
expression of CD27 can also identify γδT17 cells (IL-17-
producing γδ T cells). CD27+ γδ T cells produce IFN-γ while 
CD27− γδ T cells secrete IL-17 suggested that the surface expres-
sion CD27 can differentially mark IL-17- and IFN-γ-producing 
γδ T cells (36).
Furthermore, structural and functional heterogeneity of γδ T 
cells in EAE can be further contributed by different mice strain. 
Olive et  al. have reported amplification of Vγ5 transcript in 
C57Bl/6 mice during EAE while this transcript was not detected 
in the CNS of SJL/J mice, suggesting that the infiltrating popula-
tion of γδ T cells in CNS during disease can be varied on the basis 
of mouse strains (28).
Th17 CeLLS DiFFeReNTiATiON AND 
iL-17-PRODUCiNG γδ T CeLLS iN eAe
After the identification of Th17 cells as a separate lineage of helper 
T (Th) cells, it became clear that they, together, with Th1 cells, play 
a crucial role in EAE (37, 38). Before the identification of Th17 
cells, IFN-γ-producing Th1 cells were thought to be the primary 
effector cell type involved in the disease induction of EAE, which 
has puzzled immunologist for a very long time as both IFN-γ- and 
IFN-γR-deficient animals had exacerbated tissue inflammation in 
EAE (39). In addition, the deficiencies of IL-12p35 (IL-12) and 
IL-12Rβ2 (IL-12 receptor), which are critically required for the 
development of Th1 cells, also enhanced the development of EAE 
(37). Taken together, it is clearly suggested that Th1 cells are not 
the primary effector T cell subsets involved in development of 
EAE. In fact, Th1 cell-associated molecules, such as IFN-γ, IL-12, 
and IL-12R, negatively regulate disease and tissue inflammation 
in EAE (11). Nonetheless, Th1 cells also critical for the develop-
ment of EAE, as Th1 cells were found in the CNS in active EAE. 
In fact, a sizable population of IFN-γ and IL-17 double positive 
CD4+ T cells was found within the CNS at the peak of EAE (40).
Seminal studies demonstrated that TGF-β1 and IL-6 are 
required for the differentiation of Th17 cells (41–43). IL-6 strongly 
induces IL-21 in Th17 cells, which creates feed forward loop to 
further amplify the generation of Th17 cells (44–46). The role of 
Th17 cells and IL-17 was further demonstrated by using IL-17-
deficient mice, as Il-17−/− animals develop attenuated EAE with 
delayed onset. Moreover, the adoptive transfer of Il-17−/− CD4+ 
T cells is inefficient in transferring EAE, suggesting that IL-17 
is crucial for tissue inflammation and disease pathogenesis (47).
Similar to Th17 cells, IL-6 and TGF-β are also crucial for the 
generation of γδT17 cells (8, 48). Tgfb−/− and Smad3−/− mice har-
bor reduced precursor frequency of γδT17 cells in thymus (48). 
On the other hand, Il6−/− mice have shown reduced frequency of 
peripheral γδT17 cells (8). Taken together, similar to Th17 cells 
differentiation, TGF-β and IL-6 are crucial for the generation of 
γδT17 cells.
Importantly, the precise role of γδ T cells was demonstrated in 
EAE using Tcrd−/− mice (15, 49). Mice lacking TCR delta chain 
gene develop less severe EAE with reduced infiltration of αβ+ 
T cells in their CNS (49). Similarly, depletion of γδ T cells by 
anti-GL3 antibody before the onset or at chronic phase of EAE 
reduces the severity and clinical signs of EAE (50). Moreover, 
antibody-mediated depletion of γδ T cells regulates the influx of 
proinflammatory cytokines, such as IL-1, IL-6, TNF-α, lympho-
toxin, and IFN-γ, further suggesting an essential role of γδ T cells 
in contributing to the pathogenesis of EAE (50). Furthermore, it is 
demonstrated that the depletion of γδ T cells from MBP-reactive 
lymph node cells transferred attenuated EAE with reduced T cells 
proliferation and IL-12 secretion (51). Moreover, replenishing γδ 
T cells population not only enhanced the severity of EAE but also 
restored the IL-12 production and T cells proliferation (51).
In addition, a detailed systematic analysis of γδ T cells was 
performed to understand their distribution in different phases 
of EAE (52). Interestingly, an increased frequency of γδ T cells 
(up to 12% of total CD3+ T cells) was found in the CNS dur-
ing the acute phase while the percentage of γδ T cells decreased 
(from 12 to 5% of total CD3+ T cells) during the recovery phase 
of EAE (52). Since the frequency of myelin-specific Foxp3+ Treg 
cells increases during recovery phase of EAE, it is possible that 
the increased number of Foxp3+ Tregs contributes in controlling 
the expansion of γδ T cells population during recovery phase of 
EAE (8, 53). Interestingly, the contraction of γδ T cells popula-
tion was restricted only to the CNS, as their percentages in spleen 
remained low (~2% of total CD3+ T cells) during all phases of 
EAE. This implies that γδ T cells selectively accumulate in the 
target tissue during tissue inflammation to enhance severity of 
inflammation in EAE (52).
Although αβ+ CD4+ T cells are suggested to be the primary 
source of IL-17 in infection and autoimmune inflammation, 
γδT cells can be a potent source of IL-17, and in some cases, 
even more dominant than Th17 cells (6, 33, 54). In fact, in the 
model of Fas-ligand-induced inflammation in which injecting 
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FasL-expressing tumor cells into peritoneum of mice induces 
enhanced production of IL-17 from non-conventional T cells (55). 
Interestingly, the majority of these IL-17-producing cells were γδ 
T cells as compared to αβ Th17 cells in this particular model (55). 
Similarly, γδ T cells isolated from Mycobacterium-infected lung 
and spleen produce massive amounts of IL-17 as compared to αβ 
Th17 cells (56). Furthermore, in other model of infection, such 
as Escherichia coli, Bacillus subtilis, and experimental sepsis, γδ T 
cells, rather than αβ+ Th17 cells, are the primary source of IL-17 
(33, 57). Hence, in certain conditions, γδ T cells appear to have an 
inherent ability to rapidly produce substantial amounts of IL-17 
without being primed.
Although, initial studies identified that IL-17-producing γδ T 
cells are essential for clearing infections, the role of γδ T cells 
are also suggested for inducing autoimmune inflammation and 
propagation of autoimmune diseases, including EAE (15).
In addition to Th17 cells, Th1 cells were also implicated in 
the development of EAE (58). In fact, many studies suggested 
that myelin-specific Th1 cells adoptively transfer EAE (58). 
Interestingly, the initiation of EAE development by adoptively 
transferred myelin-specific Th1 cells resulted in recruitment of 
IL-17-producing host cells (IL-17hc) to the CNS (59). Further 
cellular characterization revealed that γδ T cells comprising 
almost 60% of the total IL-17hc (59). Moreover, in the absence 
of IL-17hc, myelin-specific Th1 cells transferred less severe EAE, 
suggesting the requirement of host production of IL-17, largely by 
γδ T cells, in the development of EAE (59).
PROiNFLAMMATORY CYTOKiNeS THAT 
iNDUCe iL-17 FROM γδ T CeLLS iN 
iNFLAMMATiON iN CNS DURiNG eAe
Progression and development of tissue inflammation in EAE are 
primarily mediated by infiltrating mononuclear cells, which pro-
duce proinflammatory cytokines. Among other CNS-infiltrating 
cells, γδ T cells predominantly and rapidly produce proinflam-
matory cytokines to further enhance tissue inflammation in EAE. 
Like conventional αβ T cells, γδ T cells also expand in secondary 
lymphoid organs upon immunization with MOG/CFA. Once 
migrated to the CNS in β2 integrin-independent manner, these 
γδ T cells further expand and accumulate shortly before the peak 
of EAE and produce IFN-γ, TNF-α, and IL-17 to further enhance 
disease progression (60, 61).
Unlike αβ Th17 cells, which require primary (TCR), second-
ary (costimulation) and cytokine signals (TGF-β1  +  IL-6) to 
produce IL-17, γδ T cells can produce IL-17 with cytokine signals 
(IL-23 and IL-1β) alone in the absence of primary and secondary 
signals (7). This peculiar feature of γδ T cells make them superior 
IL-17 producers by capturing the initial burst of proinflammatory 
cytokines produced by dendritic cells (DCs) and macrophages 
in response to TLR and NLR activation in EAE. The ability of 
γδ T cells to generate an initial burst of IL-17 in the absence of 
activation of αβ T cells is critical for initiating CNS inflammation, 
as Tcrd−/− mice develop less severe EAE with reduced production 
of IL-17 (7, 49). Moreover, αβ T cells from Tcrd−/− mice produce 
lower amounts of IL-17 as compared to αβ T cells from wild-type 
mice (8), which clearly suggested that the presence of γδ T cells 
is essentially required for optimal production of IL-17 by αβ T 
cells. Interestingly, Il1r−/− mice are substantially more resistant to 
EAE development (62); however, reconstituting IL-1R-sufficient 
γδ T cells into Il1r−/− mice prior to MOG immunization enhances 
progression of EAE, suggesting that IL-1β–IL-1R interaction on 
γδ T cells is essential for promoting tissue inflammation in EAE 
(7). Furthermore, stimulation of γδ T cells with IL-1β together 
with IL-23 synergistically enhanced IL-17 production in the 
absence of TCR stimulation (7). In addition to IL-17, other Th17 
cell-associated cytokines, such as IL-17F, IL-21, and IL-22, were 
also produced by γδ T cells upon their activation with IL-1β and 
IL-23 (Figure 1). Consistently, culture supernatant of IL-1β− and 
IL-23-stimulated γδ T cells further enhanced IL-17 production 
from αβ+ CD4+ T cells (7, 8). Neutralization of IL-21 and IL-17 
reduced IL-17 induction from αβ+ CD4+ T cells induced by 
culture supernatant of IL-1β- and IL-23-stimulated γδ T cells 
(7, 8). In fact, it is suggested that the combination of IL-1β- and 
IL-23-stimulated γδ T cells provides early burst of IL-21, which 
not only enhances production of IL-17 by the γδ T cells but it can 
also amplify the generation of Th17 cells (8, 11, 45) (Figure 1).
In addition to IL-21, another common γ chain family cytokine, 
IL-2 also play a role in generation of γδT17 cells. IL-2, which is 
known to suppress Th17 cells (63), promotes γδT17 cells genera-
tion, as Il2−/− and Cd25−/− mice selectively reduced the frequency of 
γδT17 cells (64). Interestingly, the new subset of IL-15-producing 
γδ T cells (γδT15) was recently identified in EAE (65). γδT15 cells 
suggested to enhance tissue inflammation in EAE by enhancing 
the functions of CD44hi memory T and Th17 cells (65). However, 
whether these γδT15 cells express other inflammatory cytokines, 
such as IL-17 and GM-CSF, are not clear. In summary, various 
cytokines signals are required for the generation of γδT17 cells; 
and interestingly, some of these cytokines can directly activate 
γδ T cells without the requirement of TCR activation. Taken 
together, the initial burst of proinflammatory cytokines produce 
by γδ T cells is crucial for induction of EAE.
iL-18 PROMOTeS iL-17 iNDUCTiON 
FROM γδ T CeLLS iN eAe
IL-18, an IL-1 family cytokine, also known as IFN-γ-inducing 
factor. It has been shown that IL-18 further enhances the develop-
ment of IL-12-induced Th1 cells. Moreover, Th1 cells sensitized 
with IL-18 enhance their disease promoting effector functions in 
EAE by activating IFN-γ-producing NK cells (66). The function 
of IL-18 in EAE was described using IL-18R1-deficient animals. 
Il18r1−/− mice were completely resistant to development of EAE, 
suggesting the role of IL-18R in inducing encephalitogenic T 
cells in disease (67). Moreover, the engagement of IL-18Rα on 
antigen-presenting cells is essential for generation of patho-
genic Th17 cells during EAE (67). In fact, caspase-1-processed 
cytokines IL-1β and IL-18 predominantly promote innate 
production of IL-17 from γδ T cells in EAE (9). Immunization 
with CFA, which contains heat-killed cell wall of Mycobacterium 
tuberculosis, activates caspase-1 via NLRP3 inflammasome to 
induce active forms of IL-1β and IL-18 from DCs. Inhibition of 
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caspase-1 by its specific inhibitor suppresses EAE development 
and IL-17 production from γδ T cells (9). Similar to IL-23R, γδ 
T cells also express IL-18R constitutively on their surface even 
in the steady state (Figure 2). On the contrary, the expression of 
IL-18R on CD4+ T cells is induced in inflammatory conditions 
during EAE, suggesting that γδ T cells, and not CD4+ T cells, 
respond first to the IL-18 in order to induce IL-17 production. 
It has been shown that the combination of IL-18 together with 
IL-23 rapidly induced innate production of IL-17 from γδ T cells 
in the absence of TCR stimulation (Figure 2). This initial burst of 
IL-17 from γδ T cells may be required for initiation of EAE and 
the development of pathogenic Th17 cells. It is, however, unclear 
whether coexpression of IL-23R and IL-18R on γδ T cells make 
them more pathogenic in initiating EAE.
GM-CSF-PRODUCiNG γδ T iN TiSSUe 
iNFLAMMATiON DURiNG eAe 
DeveLOPMeNT
In addition to IL-17 and IFN-γ, GM-CSF is also essentially required 
for the development of EAE. GM-CSF-deficient mice are resistant 
to the development of EAE with reduced infiltration of effector T 
cells into the CNS (68). Rostami et al. reported that the neutrali-
zation of GM-CSF-attenuated tissue inflammation in EAE (69). 
Taken together, it is clearly suggested that GM-CSF is required 
for the induction of encephalitogenic T cells in EAE. In fact, both 
Th1 and Th17 cells were shown to produce GM-CSF, which can 
further enhance the encephalitogenicity of these effector T cells in 
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mediating the development of EAE. Moreover, it is proposed that 
GM-CSF is critical for the induction of pathogenic Th17 cells in 
EAE. Although both IL-12 and IL-23 can induce the production 
of GM-CSF by the effector T cells, it is clearly demonstrated that 
IL-23, but not IL-12, signaling is critically required for GM-SCF 
production in EAE (70–72). Similarly, exposure of IL-23 enhances 
the pathogenic functions of Th17 cells mediated by GM-CSF in 
EAE. In addition to CD4+ T cells, macrophages, and NK cells, 
γδ T cells produce high amounts of GM-CSF, which contributes 
to neuroinflammation of CNS in EAE (68). In fact, γδ T cells 
are the major innate source of GM-CSF in the CNS during EAE 
development (10). Combination of IL-23 together with IL-1β 
promotes GM-CSF production from γδ T cells in the absence 
of TCR stimulation (10). Moreover, the production of GM-CSF 
induced by IL-23 and IL-1β was compromised in Il1r−/− γδ T cells. 
In fact, production of GM-CSF by CNS-infiltrating γδ T cells is 
abolished in Il1r−/− mice, suggesting that IL-1 signaling is crucial 
for generation of GM-SCF-producing γδ T cells in EAE (Figure 2) 
(10). Caspase-1, which is required for active IL-1β production, is 
also critical in inducing GM-CSF from γδ T cells, as caspase1−/− γδ 
T cells are defective in GM-CSF production. In fact, caspase1−/− 
and Il1b−/− mice share a similar EAE phenotype, suggesting a 
specific role of caspase-1 and downstream IL-1β in regulating 
the induction of GM-CSF during EAE (10). It is suggested that 
GM-CSF contribute to the development of EAE by enhancing 
the functions of CNS-resident myeloid cells, including microglial 
cells (70). Although IL-1 signaling is required for the generation 
of GM-CSF-producing γδ T cells within the CNS during EAE, it is 
not identified which subtype of γδ T cells predominantly produce 
GM-CSF during disease. Moreover, IL-1- and IL-23-mediated 
inductions of GM-CSF in γδ T cells are dependent on MyD88 
signaling, as γδ T cells from MyD88-deficient mice severely 
reduced GM-CSF production (10). Since MyD88 is a major down-
stream signaling component of TLR signaling pathway, it might 
be possible that ligation of TLRs on γδ T cells can also induce 
IL-17 production (57). To precisely understand the role TLRs in 
generating γδT17 cells, Dong et  al. used IL-17-RFP⋅KI mice to 
understand the cellular source of IL-17 in EAE in response to 
TLR4 ligation. Using a faithful IL-17 reporter system, Dong et al. 
clearly demonstrated that the expression of TLR4 is high on IL-17+ 
as compared to IL-17-γδ T cells (31). In addition to IL-17 expres-
sion, IL-23-stimulation strongly enhanced the expression of TLR4 
on γδ T cells. Moreover, the combination of IL-23 together with 
LPS further enhanced the secretion of IL-17 from γδ T cells (31). 
In addition to induced IL-17 production, TLR4 signaling also 
enhanced the survival of γδ T cells, which can further contribute 
in enhancing tissue inflammation in EAE. Taken together, TLRs 
especially TLR4 plays an essential role in inducing the develop-
ment of IL-17-producing γδ T cells and their survival.
γδ T CeLLS MAKe αβ+ CD4+ T CeLLS 
ReFRACTORY TO TReG SUPPReSSiON 
iN eAe
Regulatory T cells are critical for maintaining immune 
homeostasis of the host as loss of these cells either by naturally 
occurring mutation or cellular ablation leads to overwhelming 
activation of effector T cell-mediated multiple organ failure 
of the host (73–75). The critical functions of Treg cells were 
described in various models of autoimmune diseases, including 
EAE (53, 76). Using MOG tetramer and Foxp3-GFP⋅KI mice, it 
has been demonstrated that myelin–antigen-specific Treg cells 
are primed and expanded during the priming phase of EAE (53). 
Similar to effector T cells, these myelin-specific Treg cells can 
effectively migrate to the CNS (53). Although their frequency 
within the CNS is lower during the peak of EAE, strikingly, the 
population of Treg cells outnumber the population of effector 
T cells within the CNS at recovery phase of EAE (53). These 
CNS-accumulated Treg cells produce both IL-10 and TGF-β, 
which help in resolving the inflammation at the recovery phase 
of EAE. Interestingly, both Tr1 and Treg cells were shown to 
produce IL-10 in the CNS during the recovery phase of EAE 
(53, 77). In spite of their presence in the CNS at the peak of EAE, 
Treg cells failed to suppress proliferation and effector functions 
of CNS-accumulated effector T cells (53). Interestingly, cytokine 
analysis of CNS-accumulated effector CD4+ T cells revealed a 
strikingly higher production of proinflammatory cytokines, 
such as IL-6, TNF-α, and IL-21, which can be accounted for the 
failure of suppressive functions of Treg cells in EAE (53, 78). 
Interestingly, the higher frequency of γδ T cells together with 
αβ effector T cells found to be accumulated within the CNS (7, 
8, 53, 76). In general, γδ T cells have high expression of IL-23R, 
in fact, all the γδ T cells present in the CNS at the peak of EAE 
exclusively expressed IL-23R (8, 13). Moreover, the frequency of 
IL-23R+ γδ T cells contracts while the frequency of Tregs cells 
increases during the recovery phase of EAE (8, 53). This raised 
an interesting possibility that the presence of γδ T cells within the 
CNS might promote the functions of inflammatory αβ+ T cells 
while hampering the suppressive functions of Treg cells in EAE 
(Figure 1). In fact, Tcrd−/− mice mount-attenuated effector αβ T 
cells response in EAE, supporting the fact that the presence of γδ 
T cells are essential for effective CD4+ T cells effector functions 
in EAE (49). Interestingly, Korn et al. suggested a mechanism 
by which γδ T cells enhanced the effector functions of CD4+ 
T cells during inflammation (8). Activation of γδ T cells with 
IL-23 produced soluble factors, which make αβ+ T cells refrac-
tory to Treg cell-mediated suppression, as cellular supernatant 
of IL-23-activated γδ T cells inhibited the suppressive functions 
of Treg cell (7, 8). It has been demonstrated that Treg cells can 
lose their suppressive functions in the presence of inflammatory 
environment. In fact, IL-6 makes αβ effector T cells refractory to 
the suppressive activity of Tregs cells (8, 53, 78). In addition, IL-6 
has also been shown to inhibit TGF-β-induced de novo conver-
sion of conventional T cells into Treg cells (41, 42). Similarly, 
Kuchroo et al. has demonstrated that IL-21, in addition to IL-6, 
can also suppress TGF-β-mediated de novo conversion of con-
ventional T cells into Treg cells. Interestingly, IL-23R-stimulated 
γδ T cells not only block the conversion of conventional T cells 
into Treg cells but also make αβ+ effector T cells refractory to 
Treg cells suppression in vivo (8). This clearly indicates that the 
presence of γδ T cells at the site of tissue inflammation within the 
CNS indirectly promote the effector functions of αβ+ T cells by 
restraining their de novo conversion into Treg cells and inhibiting 
TABLe 1 | Major γδ T cells subset in mouse.
γ/δ usage Characteristic Tissue location
Vγ1 Produce IL-4. Regulatory functions 
in EAE by promoting Treg cells 
functions (34)
Majorly found in 
circulation, lymphatics, 
spleen, lymph nodes
Vγ4 Produce IL-17 and express IL-23R. 
Promote EAE and CIA. Also 
promote virus-induced encephalitis 
(6–8, 27, 35, 83)
Lymphoid tissue and lung, 
also found in CNS in EAE
Vγ5 Regulation of skin inflammation 
by maintaining the epidermal 
homeostasis (84, 85)
Skin and epidermis
Vγ6 Produce IL-17, IL-22, IFN-γ, and 
express IL-23R (27)
Mucosal tissues, 
reproductive tract, tongue, 
lung and kidney. Also 
detected in CNS during 
EAE
Vγ7 Prevent colitis by protecting intestinal 
barrier functions (57, 86, 87)
IEL and intestine
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the suppressive functions of Treg cells in EAE (7, 8) (Figure 1). 
Similarly, the role of IL-23 in restraining the suppressive func-
tions of Treg is well described in intestinal inflammation, as 
the frequency of inducible Foxp3+ Treg (iTreg) cells increases 
in the absence of IL-23 (79). However, it is not clear whether 
appearance of increased frequency of iTreg cells in the absence 
of IL-23–IL-23R signaling in the intestinal inflammation is due 
to loss of IL-23R+ γδ T cells functions, which are known to sup-
press the conversion of conventional T cells into Treg cells (8). 
Moreover, the importance of γδ T cells in mediating the inhibi-
tion of suppressive functions of Treg cells was further elucidated 
in Tcrd−/− mice, as these mice develop attenuated EAE with 
reduced production of IL-17 due to increased frequency of Treg 
cells (7, 49). Strikingly, anti-CD25 antibody-mediated depletion 
of Treg cells in Tcrd−/− mice enhanced the development of EAE 
with increased production of IL-17 (8). Altogether, it suggests 
that γδ T cells are crucial cellular component in promoting 
inflammation in EAE by restraining the regulatory functions of 
Treg cells and promoting the functions inflammatory αβ T cells 
(Figure 2).
γδ T CeLLS: PATHOGeNiC OR 
PROTeCTive iN eAe?
While some models of EAE suggest that γδ T cells are patho-
genic, others suggest that they modulate disease; thus, their 
precise role in pathogenesis is unclear. Both disease-promoting 
and disease-preventing functions of γδ T cells were documented 
in EAE. Deficiency of γδ T cells on B10⋅PL background develop 
a chronic EAE as compared to the development of monophasic 
acute EAE in the control mice (30). It has been further shown 
that γδ T cells regulate chronic inflammation by Fas–FasL-
mediated killing of CNS-infiltrating inflammatory T cells (30). 
These studies clearly suggested the protective role of γδ T cells 
in EAE development.
Although recent literature on γδ T cells in context of IL-17 
production implicated the pathogenic role of these cell types in 
EAE, a number of studies have ascribed the protective role of γδ T 
cells in EAE (30, 80, 81). A number of factors, such as using differ-
ent mice strains in combination with either depleting antibodies 
or genetic manipulation of γδ T cells, might be contributing to 
these conflicting observations. Treatment of mice with UC7-
13D5 anti-γδ antibody accelerates the onset of EAE (80). Similar 
results were obtained with the usage of UC7-13D5 antibody in 
other models of autoimmunity. It is partially identified that differ-
ent subtypes of γδ T cells such as Vγ1 produce regulatory or Vγ4 
and Vγ6 produce inflammatory cytokines (Table 1); therefore, it 
is possible that the treatment of UC7-13D5 antibody may alter 
this ratio and activate different subtypes of γδ T cell populations 
by cross-linking their TCR at different phases of EAE, which 
results in different outcome of disease. Nonetheless, it was not 
clearly understood whether anti-pan γδ T cells antibody depletes 
or activates γδ T cells by cross-linking their TCR in EAE (80). 
Using Tcrd-GFP knock-in mice, it has been clearly demonstrated 
that treatment with anti-pan γδ T cell antibodies activates, rather 
than depletes, γδ T cells and therefore exacerbating EAE (34). 
In addition, Tcrd−/− mice develop chronic inflammation in some 
mouse model of EAE (82). Tcrd−/− mice are devoid of δ TCR, 
which allow γδ T cells not to be activated by their TCR stimula-
tion; however, the number of γδ T cells in these mice remains 
unchanged. This indicates that TCR-independent activation of γδ 
T cells can still occur in Tcrd−/− mice. We have discussed those 
different subsets of γδ T cells play opposite roles in EAE develop-
ment. An interesting dichotomy has been established among Vγ1 
and Vγ4 subsets of γδ T cells in EAE, which further provide a 
logical explanation for previously published contradictory results. 
Specific antibody-mediated activation of Vγ4 γδ T cells promote 
the development of EAE associated with enhanced production 
of IL-17 (34). On the other hand, specific antibody-mediated 
activation of Vγ1 γδ T cells suppressed EAE development (34). 
Interestingly, it has recently shown that γδ T cells can be activated 
with proinflammatory cytokines without the requirement of their 
TCR signals. To further identify the pathogenic or protective role 
of γδ T cells in EAE, a detailed study, including the involvement 
of various subtypes of γδ T cells, is required with more definitive 
tools. Nonetheless, accumulated literature in other autoimmunity 
has suggested that γδ T cells might play a pathogenic role in EAE. 
We have summarized the chief findings of γδ T cells in EAE in 
Table 2.
ReLevANCe OF γδ T CeLLS iN MULTiPLe 
SCLeROSiS
Multiple sclerosis is demyelinating disease of CNS, which is 
caused by inflammatory T cells. In addition to αβ+ CD4+ T cells, 
γδ T cells were also clearly implicated in the disease pathogenesis 
in MS. It is shown that γδ T cells are accumulated in the MS 
plaques (90, 91). A restricted repertoire of γδ T cells was identi-
fied in MS lesions. CNS-restricted γδ T cells abundantly express 
variable gene segments Vδ1 and Vδ2. Furthermore, Vγ9+ γδ T 
cells circulate abundantly in the blood of MS patients and can be 
TABLe 2 | Chief findings of γδ T cells in eAe.
Gene deficiency/treatment Consequence effect in eAe
Anti-γδ T cells (clone GL3) monoclonal antibody treatment in 
EAE
Reduction in disease pathology. Significant reduction in clinical sign in acute 
phase of EAE
Protection (52)
Anti-γδ T cells (clone UC7-13D5) monoclonal antibody 
treatment in EAE
Significant reduction in demyelination and reduction in limb paresis Protection (88)
Active EAE development in delta (d) chain-deficient mice Significant reduction in clinical score of EAE with enhanced frequency of Foxp3+ 
Tregs
Protection  
(8, 49)
EAE induction by adoptively transferring MOG-specific Wt 
T cells into delta (d) chain-deficient mice
Significant reduction in clinical score of EAE with no cellular infiltration in CNS Protection (49)
MBP-specific γδ T cells depleted (clone: GL3) lymph node cells 
were adoptively transferred to induce EAE
Significant reduction in clinical score in EAE with a significant reduction in IL-12 
production
Protection (51)
Activation of Vγ4 subset with anti-Vγ4 TCR (UC3) antibody 
treatment in EAE
Worsen EAE with enhanced IL-17 response Promote  
EAE (34)
Activation of Vγ1 subset by anti-Vγ1 TCR antibody (2.11) 
treatment in EAE
Significant reduction in clinical score of EAE with less proinflammatory cytokines 
production
Protection (34)
EAE in IL-23R-deficient mice and effect of IL-23–IL-23R axis 
on γδ T cells
IL-23R-deficient mice are resistant to EAE. γδ T cells constitutively express 
IL-23R. Almost all γδ T cells express IL-23R in CNS in EAE and produce IL-17
Protection  
(8, 13)
EAE in IL-18R-deficeint mice and effect of IL-18R on γδ T cells IL-18R-deficient mice are protected from EAE. IL-18R−/− failed to produce IL-17 Protection  
(9, 67)
EAE in IL-1R-deficent mice and effect of IL-1R on γδ T cells IL-1R-deficient mice are protected from EAE. IL-1R1−/− γδ T cells are defective in 
IL-17 and GM-CSF production in EAE
Protection  
(7, 10, 62)
EAE in caspase-1-deficient mice and effect of caspase-1 on γδ 
T cells
Significantly reduced clinical sign of EAE. Defective production of IL-17 and 
GM-CSF from caspase-1-deficient γδ T cells
Protection  
(9, 10, 89)
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used as an indicator of disease activity (92). With the emerging 
literature on γδ T cells in EAE, it is indicated the involvement of 
γδ T cells in the pathogenesis of disease (see Table 1). Mouse data 
in EAE clearly indicated that IL-17-producing γδ T cells are cru-
cial for disease induction and tissue inflammation in EAE (8, 10). 
Moreover, the role of IL-23, IL-1, IL-18, and caspase-1 is clearly 
indicated in enhancing IL-17- and GM-CSF-producing γδ T cells 
in EAE. Recent advancements in understanding the biology of 
Th17- and IL-17-producing γδ T cell and their implication in 
autoimmune diseases, including MS, could suggest new thera-
peutic targets for MS by targeting Th17- and IL-17-producing 
γδ T cells populations.
CONCLUSiON
A number of studies have demonstrated a potential role of γδ 
T cells in the induction and maintenance of demyelinating 
CNS inflammation. γδ T cells are multifaceted cells, which are 
equipped with variety of functions to potentially influence all 
levels of inflammation by recognizing diverse array of antigens, 
rapid production of inflammatory mediators, and influenc-
ing the differentiation of their αβ counterparts. Equipped 
with functions of both innate and adaptive immune cells, γδ 
T cells can provide consequential functions in EAE develop-
ment. Opposing roles of different subtypes of γδ T cells have 
been described in different mouse strains in EAE. Moreover, 
the identification of IL-17-producing inflammatory γδ T cells 
suggested their pathogenic role in EAE. In fact, many of the 
key questions in autoimmune inflammation, including EAE, 
were resolved by the discovery of IL-17-secreting Th17 cells. 
Moreover, clarification on the indispensible role of IL-23–
IL-23R axis in Th17 cells also urged researchers to identify the 
role of IL-23–IL-23R signaling in γδ T cells as they have high 
expression of IL-23R receptor and therefore are responsive to 
IL-23 even in steady state – a characteristic which naive αβ T 
cells lack. This revisits the importance of IL-23 in the settings 
of EAE since it can influence the generation of two pathogenic 
subsets Th17 cells and γδT17 cells both of which contributes 
IL-17 to large extent. Synergistic action of IL-23, IL-1β, and 
IL-21 induces inflammatory IL-17-producing-γδ T cells, which 
not only enhance the generation and functions of αβ+ Th17 cells 
but also obstructs the suppressive functions of Treg cells in EAE. 
Recently, significant progress has been made in understanding 
the pathogenic role of γδ T cells in tissue inflammation. Yet more 
substantial evidences are required on different subtypes of γδ T 
cells for defining their opposing roles in tissue inflammation 
and explaining the confounding findings on their pathogenic or 
protective role in EAE.
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